CLINICAL_TRIALS
trial_result
· 2017-12-28
Clinical Trial Update: Efficacy and Safety of Oral Treatment With BIBF 1120 ES in Advanced Non-small-cell Lung Cancer [Phase 2]
Summary
Phase 2 trial assessing efficacy and safety of oral BIBF 1120 ES in advanced non-small-cell lung cancer completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED